Raymond D Blind

15PUBLICATIONS
20CO-AUTHORS
Proteomics and intermolecular interactions (excl. medical proteomics)Cheminformatics and quantitative structure-activity relationshipsProteins and peptidesBiologically active moleculesPharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Nov 24, 2025
Structural rationalization of IPMK inhibitor potency.

Huanchen Wang, Stephen B Shears, Raymond D Blind

|Nov 14, 2025
Structural Rationalization of IPMK Inhibitor Potency.

Huanchen Wang, Stephen B Shears, Raymond D Blind

|Jun 10, 2024
Bilirubin is a new ligand for nuclear receptor Liver Receptor Homolog-1.

Pratima Chapagain, Zeinab Haratipour, M Merced Malabanan

|May 28, 2024
Hippo and PI5P4K signaling intersect to control the transcriptional activation of YAP.

Lavinia Palamiuc, Jared L Johnson, Zeinab Haratipour

Pageof 3